首页> 外国专利> ANTIBODIES THAT BIND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)/DELTA-LIKE 4 LIGAND (DLL4) AND USE THEREOF

ANTIBODIES THAT BIND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)/DELTA-LIKE 4 LIGAND (DLL4) AND USE THEREOF

机译:结合血管内皮细胞生长因子(VEGF)/δ样4配体(DLL4)的抗体并使用

摘要

The present invention relates to VEGF-binding agents, DLL4-binding agents, VEGF/DLL4 bispecific binding agents, and methods of using the agents for treating diseases such as cancer. The present invention provides antibodies that specifically bind human VEGF, antibodies that specifically bind human DLL4, and bispecific antibodies that specifically bind human VEGF and/or human DLL4. The present invention further provides methods of using said agents to inhibit tumor growth. Also described are methods of treating cancer comprising administering a therapeutically effect amount of an agent or antibody of the present invention to a patient having a tumor or cancer.
机译:本发明涉及VEGF结合剂,DLL4结合剂,VEGF / DLL4双特异性结合剂,以及使用这些试剂治疗疾病如癌症的方法。本发明提供了特异性结合人VEGF的抗体,特异性结合人DLL4的抗体和特异性结合人VEGF和/或人DLL4的双特异性抗体。本发明进一步提供了使用所述试剂抑制肿瘤生长的方法。还描述了治疗癌症的方法,该方法包括向患有肿瘤或癌症的患者施用治疗有效量的本发明的试剂或抗体。

著录项

  • 公开/公告号EA029958B1

    专利类型

  • 公开/公告日2018-06-29

    原文格式PDF

  • 申请/专利权人 ONCOMED PHARMACEUTICALS INC.;

    申请/专利号EA20140090622

  • 发明设计人 AUSTIN L.;AARON KEN;CHRISTOPHER JOHN;

    申请日2012-09-24

  • 分类号A61K39;C12P21/08;C07K16;

  • 国家 EA

  • 入库时间 2022-08-21 12:52:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号